Haemonetics (HAE) Peer Comparison

$120.02

up-down-arrow $-2.84 (-2.31%)

As on 19-Nov-2026 14:44EST

Market cap

info icon

$5,588 Mln

Revenue (TTM)

info icon

$1,382 Mln

P/E Ratio

info icon

54.3

P/B Ratio

info icon

6.1

Div. Yield

info icon

0 %

Edit peer-selector-edit
Haemonetics (HAE) Glaukos Corp (GKOS) Penumbra (PEN) Repligen (RGEN) Bio-Rad Laboratories
Market cap ($ Mln)
5,588 14,620 12,647 10,726 10,488
Revenue ($ Mln)
1,382 690 1,560 806 2,593
Net Profit ($ Mln)
103.91 -169.80 157.02 -11.80 1,022.90
Net Margin (%)
7.52 -24.60 10.06 -1.47 39.45
RoE (%)
12.26 -24.46 10.27 -0.56 14.15
Price to Earnings
54.30 -- 80.82 -- 10.36
Price-To-Book
6.11 20.40 7.98 5.09 1.38

Income Statement ($ Mln)

Liabilities ($ Mln)

Assets ($ Mln)

Cashflow ($ Mln)

Ratios

Profitability Ratios

Growth Ratios

Valuation Ratios

Solvency Ratios

Operating Efficiency Ratios

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month